MabVax Therapeutics Holdings, Inc.(Other OTC/NBB : MBVX)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.66% | 158.51 | 0.7% | $1180.25m | |
| MRK | Merck & Co., Inc. | 0.35% | 76.72 | 0.7% | $1003.69m | |
| PFE | Pfizer Inc. | 0.08% | 37.20 | 0.9% | $1001.79m | |
| ABBV | AbbVie, Inc. | -1.01% | 107.11 | 1.9% | $822.90m | |
| BMY | Bristol-Myers Squibb Co. | -0.38% | 63.37 | 1.0% | $730.48m | |
| LLY | Eli Lilly & Co. | 0.38% | 183.20 | 1.1% | $689.46m | |
| AZN | AstraZeneca Plc | 1.24% | 49.80 | 1.2% | $437.40m | |
| GSK | GlaxoSmithKline Plc | 0.28% | 36.14 | 0.2% | $182.12m | |
| RPRX | Royalty Pharma Plc | 0.00% | 41.43 | 0.2% | $160.14m | |
| NVS | Novartis AG | -0.04% | 86.59 | 0.2% | $151.30m | |
| VTRS | Viatris, Inc. | 0.93% | 13.09 | 0.0% | $128.95m | |
| RGEN | Repligen Corp. | 0.00% | 212.86 | 6.8% | $92.84m | |
| CVAC | CureVac NV | 4.03% | 99.50 | 0.0% | $77.60m | |
| ATNF | 180 Life Sciences Corp. | -2.32% | 10.54 | 0.0% | $62.81m | |
| SNY | Sanofi | 0.58% | 50.45 | 0.2% | $60.73m |
Company Profile
MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA.